Growth Metrics

Quest Diagnostics (DGX) Return on Equity (2016 - 2025)

Historic Return on Equity for Quest Diagnostics (DGX) over the last 16 years, with Q3 2025 value amounting to 0.14%.

  • Quest Diagnostics' Return on Equity rose 100.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.14% for FY2024, which is 100.0% down from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Return on Equity is 0.14%, which was up 100.0% from 0.14% recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Return on Equity registered a high of 0.31% during Q4 2021, and its lowest value of 0.07% during Q1 2021.
  • Moreover, its 5-year median value for Return on Equity was 0.14% (2024), whereas its average is 0.17%.
  • Examining YoY changes over the last 5 years, Quest Diagnostics' Return on Equity showed a top increase of 2200bps in 2022 and a maximum decrease of -1500bps in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' Return on Equity stood at 0.31% in 2021, then tumbled by -49bps to 0.16% in 2022, then decreased by -13bps to 0.14% in 2023, then fell by -4bps to 0.13% in 2024, then increased by 3bps to 0.14% in 2025.
  • Its Return on Equity stands at 0.14% for Q3 2025, versus 0.14% for Q2 2025 and 0.13% for Q1 2025.